MAPK3 and Hyperglycemia: The present study was designed to elucidate whether CHS protected against hyperglycemia-induced ROS explosion and Ca2+ overload by stimulating the expression of Homer1a and the involvement of SIRT1/ERK1/2 signaling in vivo and in vitro.